Donor | Groups | Rate of HDR (%) | Correction (%) |
---|
No donors | Cas9 | 4/107 (3.7) | 3/107 (2.8) |
Cas9 + SCR7 | 8/114 (7.0) | 7/114 (6.1) |
β-cateninWT-96 | Cas9 + ssODN | 13/155 (8.4) | 11/155 (7.1) |
Cas9 + ssODN + SCR7 | 22/151 (14.6)* | 21/151 (13.9)* |
- HCT-116 cells were transfected with the pCS2-Cas9-IRES-eGFP-β-catenin-gRNA(ΔTCT) co-expression vector with or without the addition of β-cateninWT-96 ssODN and SCR7 (10 μM) treatment. The rates of HDR and mutation-correction were derived from direct DNA sequencing of GFP-positive cells as described in the methods. These statistical assays were performed by One-side Chi square test
- * p < 0.05 compared to the corresponding Cas9 + ssODN group